Abstract:Objective To study the effect and mechanism of triptolide (TPL) on ameliorating renal injury of MRL/lpr lupus mice. Method Female C57BL/6 normal mice were selected as the control group, female MRL/lpr lupus mice were divided into model group, TPL group, JAK1 group and TPL+JAK1 group. 24h urine protein, serum creatinine (Scr), blood urea (BUN), fluorescence intensity of renal IgG and C3, contents of IFN-γ induced protein 10 (IP-10) and high mobility group box protein 1 (HMGB1), the expression of phosphorylated Janus kinase 1 (p-JAK1), phosphorylated signal transduction and activator of transcription 1 (p-STAT1) were detected. Result The 24 h urine protein, Scr, BUN levels, IgG and C3 fluorescence intensity, IP-10 and HMGB1 content, p-JAK1 and p-STAT1 expression in model group were higher than those in control group (P < 0.05); the 24 h urine protein, Scr, BUN levels, IgG and C3 fluorescence intensity, IP-10 and HMGB1 content, p-JAK1 and p-STAT1 expression in TPL group were lower than model group (P < 0.05); the 24 h urine protein, Scr, BUN levels, IgG and C3 fluorescence intensity, IP-10 and HMGB1 content, p-JAK1 and p-STAT1 expression in TPL+JAK1 group were higher than those in TPL group (P < 0.05). Conclusion TPL can ameliorate renal damage in MRL/lpr lupus mice, and the inhibition of inflammatory response mediated by JAK1/STAT1 pathway is a possible molecular mechanism.